Phenobarbital Versus Valproate for Generalized Convulsive Status Epilepticus in Adults: A Prospective Randomized Controlled Trial in China

被引:29
作者
Su, Yingying [1 ]
Liu, Gang [1 ]
Tian, Fei [1 ]
Ren, Guoping [1 ]
Jiang, Mengdi [1 ]
Chun, Brian [2 ]
Zhang, Yunzhou [1 ]
Zhang, Yan [1 ]
Ye, Hong [1 ]
Gao, Daiquan [1 ]
Chen, Weibi [1 ]
机构
[1] Capital Med Univ, Xuanwu Hosp, Dept Neurol, Beijing, Peoples R China
[2] Wayne State Univ, Sch Med, Dept Neurosurg, Detroit, MI USA
关键词
REFRACTORY STATUS EPILEPTICUS; INTRAVENOUS-SODIUM VALPROATE; PREHOSPITAL TREATMENT; PHENYTOIN; DIAZEPAM; MANAGEMENT; MORTALITY; ACID; BENZODIAZEPINES; LEVETIRACETAM;
D O I
10.1007/s40263-016-0388-6
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective Although generalized convulsive status epilepticus (GCSE) is a life-threatening emergency, evidence-based data to guide initial drug treatment choices are lacking in the Chinese population. We conducted this prospective, randomized, controlled trial to evaluate the relative efficacy and safety of intravenous phenobarbital and valproate in patients with GCSE. Methods After the failure of first-line diazepam treatment, Chinese adult patients with GCSE were randomized to receive either intravenous phenobarbital (standard doses, low rate) or valproate (standard). Successful treatment was considered when clinical and electroencephalographic seizure activity ceased. Adverse events following treatment, as well as the neurological outcomes at discharge and 3 months later, were also evaluated. Results Overall, 73 cases were enrolled in the study. Intravenous phenobarbital was successful in 81.1% of patients, and intravenous valproate was successful in 44.4% of patients (p < 0.05). The relapse rate of status epilepticus within 24 h of receiving phenobarbital (6.7%) was significantly lower than that in patients receiving valproate (31.3%), and the total number of adverse events did not differ significantly between the two groups (p > 0.05). In the phenobarbital group, two patients (5.4%) required ventilation and two patients (5.4%) developed serious hypotension. The neurological outcomes of the phenobarbital group were generally better than those of the valproate group; however, no significant differences were observed between phenobarbital and valproate with respect to mortality (8.1 vs. 16.6%) at discharge, or mortality (16.2 vs. 30.5%) and post-symptomatic epilepsy (26.3 vs. 42.8%) at 3-month follow-up. Conclusions Intravenous phenobarbital appears to be more effective than intravenous valproate for Chinese adult patients with GCSE. The occurrence of serious respiratory depression and hypotension caused by phenobarbital was reduced by decreasing the intravenous infusion rate; however, even at a lower infusion rate than typically used in other institutions, intravenous phenobarbital resulted in more serious adverse events than intravenous valproate. The better outcomes in the phenobarbital group compared with the valproate group suggest that phenobarbital should be considered for the early successful treatment of GCSE.
引用
收藏
页码:1201 / 1207
页数:7
相关论文
共 29 条
[1]   Randomized study of intravenous valproate and phenytoin in status epilepticus [J].
Agarwal, Puneet ;
Kumar, Navneet ;
Chandra, Rakesh ;
Gupta, Gaurav ;
Antony, Arun Raj ;
Garg, Niren .
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2007, 16 (06) :527-532
[2]  
Anyanwu E., 1993, Acta Physiologica Pharmacologica et Therapeutica Latinoamericana, V43, P20
[3]   Generalized convulsive status epilepticus management in adults: A cohort study with evaluation of professional practice [J].
Aranda, Alexandre ;
Foucart, Guillaume ;
Ducasse, Jean Louis ;
Grolleau, Sabrina ;
McGonigal, Aileen ;
Valton, Luc .
EPILEPSIA, 2010, 51 (10) :2159-2167
[4]   Intravenous levetiracetam as treatment for status epilepticus [J].
Berning, Sascha ;
Boesebeck, Frank ;
van Baalen, Andreas ;
Kellinghaus, Christoph .
JOURNAL OF NEUROLOGY, 2009, 256 (10) :1634-1642
[5]   Guidelines for the Evaluation and Management of Status Epilepticus [J].
Brophy, Gretchen M. ;
Bell, Rodney ;
Claassen, Jan ;
Alldredge, Brian ;
Bleck, Thomas P. ;
Glauser, Tracy ;
LaRoche, Suzette M. ;
Riviello, James J., Jr. ;
Shutter, Lori ;
Sperling, Michael R. ;
Treiman, David M. ;
Vespa, Paul M. .
NEUROCRITICAL CARE, 2012, 17 (01) :3-23
[6]   Valproate versus diazepam for generalized convulsive status epilepticus: a pilot study [J].
Chen, W. B. ;
Gao, R. ;
Su, Y. Y. ;
Zhao, J. W. ;
Zhang, Y. Z. ;
Wang, L. ;
Ren, Y. ;
Fan, C. Q. .
EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 (12) :1391-1396
[7]   Incidence of status epilepticus in French-speaking Switzerland - (EPISTAR) [J].
Coeytaux, A ;
Jallon, P ;
Galobardes, B ;
Morabia, A .
NEUROLOGY, 2000, 55 (05) :693-697
[8]   INTRAVENOUS PHENYTOIN IN ACUTE TREATMENT OF SEIZURES [J].
CRANFORD, RE ;
LEPPIK, IE ;
PATRICK, B ;
ANDERSON, CB ;
KOSTICK, B .
NEUROLOGY, 1979, 29 (11) :1474-1479
[9]   Two years of experience in the treatment of status epilepticus with intravenous levetiracetam [J].
Eue, S. ;
Grumbt, M. ;
Mueller, M. ;
Schulze, A. .
EPILEPSY & BEHAVIOR, 2009, 15 (04) :467-469
[10]   Treatment of status epilepticus and acute repetitive seizures with i.v. valproic acid vs phenytoin [J].
Gilad, R. ;
Izkovitz, N. ;
Dabby, R. ;
Rapoport, A. ;
Sadeh, M. ;
Weller, B. ;
Lampl, Y. .
ACTA NEUROLOGICA SCANDINAVICA, 2008, 118 (05) :296-300